Literature DB >> 9231338

In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: penetration of chloramphenicol from lipophilic vehicles and a nail lacquer.

D Mertin1, B C Lippold.   

Abstract

Lipophilic vehicles and especially nail lacquers are more appropriate for topical application on the nail than aqueous systems because of their better adhesion. This work has, therefore, studied the penetration through the human nail plate of the model compound chloramphenicol from the lipophilic vehicles medium chain triglycerides and n-octanol and from a lacquer based on quaternary poly(methyl methacrylates) (Eudragit RL). The results were compared with data obtained with a keratin membrane from bovine hooves. If the swelling of the nail plate or the hoof membrane is not altered by use of lipophilic vehicles, the maximum flux of the drug is independent of its solubility in the vehicle and is the same as that from a saturated aqueous solution. These vehicles are not able to enter the hydrophilic keratin membrane because of their non-polar character and so cannot change the solubility of the penetrating substance in the barrier. If the concentration of the drug in the nail lacquer is sufficiently high, the maximum flux through both barriers equals that from aqueous vehicles or even exceeds it because of the formation of a supersaturated system. Penetration through the nail plate follows first order kinetics after a lag-time of 400 h. The course of penetration through the hoof membrane is initially membrane-controlled and later becomes a matrix-controlled process because of the membrane's greater permeability. Chloramphenicol is dissolved in the lacquer up to a concentration of 31%. The relative release rates from these solution matrices are independent of the drug concentration but they decrease on changing to a suspension matrix. These results show that drug flux is independent of the character of the vehicle and that penetration of the drug is initially membrane-controlled and changes to being matrix-controlled as the drug content of the lacquer decreases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231338     DOI: 10.1111/j.2042-7158.1997.tb06788.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Influence of pH on transungual passive and iontophoretic transport.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

3.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

4.  Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

5.  Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

Review 6.  Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.

Authors:  Kevin Chen; Vinam Puri; Bozena Michniak-Kohn
Journal:  AAPS J       Date:  2021-01-13       Impact factor: 4.009

7.  Formulation of Tioconazole and Melaleuca alternifolia Essential Oil Pickering Emulsions for Onychomycosis Topical Treatment.

Authors:  Barbara Vörös-Horváth; Sourav Das; Ala' Salem; Sándor Nagy; Andrea Böszörményi; Tamás Kőszegi; Szilárd Pál; Aleksandar Széchenyi
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.